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Introduction
Central nervous systemgerm cell tumors (GCT) are very rare,
comprising approximately 0.3 to 0.6% of all primary intra-
cranial tumors,1,2 and they can be divided in following
classes: germinomas, nongerminomatous (teratoma,
embryonic carcinoma, endodermal sinus tumor, choriocar-
cinoma), and mixed GCT.2–4 Teratomas are a subtype of
nongerminomatous GCT, which originate from pluripotent
cells, which in turn are derived from all three germ cell layers
present in normal organogenesis. The majority of reported
teratomas contain tissue from all three germ cell layers
(endoderm, mesoderm, and ectoderm). However, they occa-
sionally develop from a single germ cell layer if they show
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Abstract Introduction: Primary intracranial teratoma is a subtype of germ cell tumors, classiﬁed
into three subtypes. They occur very rarely, with only several reported individual cases
in adults.
Case Description We present a patient with an intermittent headache in the right
frontal region. Magnetic resonance imaging (MRI) revealed a right sided high frontal
parasagittal mass that compressed the falx, the right lateral ventricle, as well as the
brain parenchyma. Patient underwent surgical treatment. Histopathological analysis
described mature teratoma. Four months after the surgical treatment there were no
signs of residual intracranial mass or relapse.
Discussion Primary intracranial teratoma in adults has a nonspeciﬁc clinical presenta-
tion. MRI reveals a solitary irregular mass withmultilocularity andmixed signals derived
from different tissues. The patients age, biochemical markers, and patohistological
analysis are necessary to conﬁrm the diagnosis.
Conclusion Teratoma treatment strategy still remains controversial. It includes
radical resection whenever possible. Since the residual portion of mature teratoma
may contain part of immature or malignant tissue, tumor recurrence after surgical
removal is possible. Also, new tumor mass could occur at other sites intracranial after
the initial one was removed. Thus, although patients usually recover, they should be
followed-up for a long period of time.
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histological divergent differentiation.2 Teratomas are
hypothesized to arise by a misplacement of a pluripotent
germ cell. Primary intracranial teratomas occur very rarely,
with only several individual reported cases in adults. Several
articles report that intracranial teratomas usually present in
patients between 1 and 46 years of age (mean, 14.8 years)
and have a male predominance (male to female ratio, 28:3).5
According to histologicalﬁndings, teratomas are classiﬁed
into three subtypes:mature teratomas, immature teratomas,
and teratomas with amalignant transformation.1–3,6Mature
teratomas are mainly composed of well-differentiated tissue
with low mitotic activity, while immature teratoma consist
of components resembling fetal tissue like hypercellular
embryonic mesenchyme or primitive neuroectodermal ele-
ments that can be mixed with mature tissue elements.
Teratomas with malignant transformation are extremely
rare and are characterized with additional malignant
somatic tissue.1,7 Teratomas, as well as GCT, are usually
located in the midline structures of the brain since the
midline is a locationwith a great potential for misplacement
of embryonic tissues. Teratomas can thus be usually found in
areas, such as around the third ventricle, especially the pineal
region, and the suprasellar or parasellar region. Less common
sites include the ventricular system, cerebellar vermis, basal
ganglia, cerebellopontine angle, and the cavernous sinus.1,6
Case Description
A 37-year-old female patient presented with a 4-month
history of intermittent headache in the right frontal region.
There were no other symptoms nor were there any neuro-
logical deﬁcits at the time of admission. Initial computerized
tomography (CT) and magnetic resonance imaging (MRI)
revealed a right sided extra-axial frontal parasagittal mass
measuring 8.5  4.2  6.1 cm with several calciﬁed areas
and a central necrotic part. The mass compressed the sur-
rounding brain parenchyma, especially primary motor cor-
tex, partially the right lateral ventricle, and also the superior
sagittal sinus, without inﬁltrating the aforementioned struc-
tures. Also, there was invasion and destruction of cerebral
falx. After the administration of intravenous contrast, the
mass showed marginal heterogeneous enhancement
(►Fig. 1). According to the MRI scan, differential diagnoses
included meningioma, ﬁbrous tumor of the dura mater or
other primary process of the dura.
Patient underwent a right sided parasagittal frontopar-
ietal craniotomy. A mostly calciﬁed mass with several
central soft areas that was invading and destroying a large
part of the cerebral falx (with no invasion to the superior
sagittal sinus) was completely removed. Partial duroplasty
was performed. Surgery went without any complications.
A control CT scan, performed on the ﬁrst postoperative day,
revealed a satisfactory ﬁnding, without any signs of ische-
mia, hemorrhage, or residual tumor. Patient recovered
uneventfully. Tissue samples acquired during the surgical
procedure underwent patohistological analysis. The tumor
consisted of mature cartilage tissue, several fragments of
bone tissue, and mature adipose tissue (►Fig. 2). According
to the WHO (World Health Organization) classiﬁcation, it
corresponded to a mature teratoma. An oncologist was
consulted. There was no indication for further oncological
treatment and the patient afterwards underwent regular
radiological follow-up.
Four months afterwards, an MRI as well as a further
neurosurgical control was performed. Patient was without
any neurological deﬁcits or headaches. MRI revealed a
satisfying postoperative result without recurrence of intra-
cranial masses (►Fig. 3).
Discussion
Teratomas are usually seen as a solitary irregular mass with
or without multilocularity and mixed signals derived from
different tissues. After intravenous contrast administration
teratomas usually show heterogeneous enhancement on
the MRI, while its internal architecture is best displayed on
T1- and T2-weighted images. Perilesional cerebral edema
isn’t usually present, due to the presence of the tumor
Fig. 1 Initial brain MRI showing right sided extra axial high parietal parasagittal mass in (A) transverse plain, T1-weighted image; (B) transverse
plain, T2-weighted image; and (C) coronal plain, T1-weighted image. Note the marginal heterogeneous enhancement of the tumor after the
administration of intravenous contrast (A). MRI, magnetic resonance imaging.
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capsule as well as the undamaged blood brain barrier.
MRI signal intensity reﬂects the various types of tissue
within teratomas, such as ﬁbrosis, adipose tissue, calciﬁca-
tion, cystic elements, hair follicles, cellular debris, and
keratinocytes.1,2
Clinically, the incidence of teratomas decreases with age.
The patient’s clinical presentation is nonspeciﬁc, depending
on the tumor size and location, with signs of increased
intracranial pressure as the most common one.1,6
Before the diagnosis of a teratoma is established, it is
important to exclude other intracranial neoplasms. The
patient’s age and biochemical markers, such as serum alpha-
fetoprotein (AFP) and β-human chorionic gonadotropin (b-
HCG), can be useful in differentiating teratomas from other
intracranial neoplasms. If elevated, serum AFP levels are
strongly indicative of a malignant teratoma. Spotted calciﬁca-
tion and adipose components revealed using CT or MRI scans
are characteristic for intracranial teratomadiagnosis.1,6,7Deﬁ-
nitive diagnosis is conﬁrmed using a patohistological ﬁnding.
Asmentioned earlier, teratomas are divided into three further
subtypes dependingon thematurityof their tissue. In addition
to the mature and immature subtypes, teratomas can also
manifest a great number of mitoses in an immature tissue
sample, indicating a teratoma with a malignant transforma-
tion.6 It is of great importance to determine the exact pato-
histological diagnosis using extensive sampling, as immature
tissue can constitute even a minor part of the tumor and
therefore direct to another treatment option.8,9
Fig. 2 Microphotography of a patohistological section of a removed teratoma stained with hemalaun eosin: (A and B) cartilage, magniﬁcation of
40; (C) cartilage, magniﬁcation of 200; (D) cartilage and adipose tissue, magniﬁcation of 40; (E) bone and cartilage, magniﬁcation of 40;
and (F) bone and cartilage, magniﬁcation of 100.
Fig. 3 Brain MRI scans, four months postoperatively, (A) transverse plain, T1-weighted image; (B) transverse plain, T2-weighted image; (C)
coronal plain, T1-weighted image. Note how there is no recurrence or additional intracranial mass in the images. MRI, magnetic resonance
imaging.
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There are two main theories that could explain the
pathogenesis of GCT in the central nervous system. While
the germ cell theory suggests that teratomas arise from
primordial germ cells whichmigrated during embryogenesis
and underwent malignant transformation, the embryonic
theory suggests that teratomas arise from a mismigrational
pluripotent germ cell.6,7 Since the brain midline structures
are mostly affected with teratomas, and since the cerebral
falx, the cavernous sinus walls, as well as the septum
pellucidum are histological the same as the dura mater, it
has been suggested that the abnormal migration of primor-
dial germ cells into the dura mater might be responsible for
the occurrence of intracranial mature teratomas.7 It has also
been hypothesized that this kind of migration is under the
control of complex molecular events.6
Several reported cases showed that new teratomas could
occur at other intracranial sites after an initial one was
removed. These cases suggest that the pathogenesis of ter-
atomas might be associated with genetic alterations. Experi-
mental analyses demonstrated that teratomas harbored a
genetic loss or mutation, such as the loss of heterozygosity
in theE-cadheringeneand themutation in the exon-3of theβ-
catenin gene, which are components of adherent junctions.
Morphological changes that occur as a consequence of genetic
changes could be an important factor in tumorigenesis.7,10
So far, teratoma treatment strategies still remain contro-
versial. Treatment includes radical resection whenever pos-
sible, with surgical approach depending on the location of
the teratoma. Excision is considered complete if more than
90% of the tumor has been removed.6 As mature teratomas
are considered radioresistent, total tumor removal is the
treatment of choice.4 The clinical outcome in patients with
primary intracranial teratomas is dependent on the pathol-
ogy. Since any residual portion of a diagnosed mature
teratoma may also contain a small part of immature or
malignant tissue, recurrence after its partial removal has
indeed previously been reported. Previous studies report a 5-
year survival rate for patients with an immature or mature
teratomawith a malignant element in between 44 and 68%.7
Although mature teratoma has a low recurrence rate after
surgical resection, various articles report occurrence of other
GCTs on different intracranial sites.11,12 While patients
usually recover uneventfully, they should be followed-up
for a longer period, since malignant teratomas or new
teratomas may arise intra- or extracranially.
Conclusion
We reported a case of a patient with a mature teratoma that
destroyed a large part of the cerebral falx which in fact can
also be its starting point. This observation can go in favor of
abnormal migration of primordial germ cells into the dura or
better said in favor of the embryonic theory. Radical resec-
tion, whenever possible, is the treatment option for terato-
mas. As new or recurrent teratomas (or other GCT) might
appear, a long period follow-up is essential in patients that
undergo surgical procedure for intracranial teratoma.
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